The American Lawyer profiled Nancy Lieberman as its “Dealmaker in the Spotlight” for her role in Amylin Pharmaceuticals, Inc.'s agreement with Eli Lilly and Company to terminate their alliance for the diabetes drug exenatide.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates